.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Johnson and Johnson
McKinsey
UBS
Julphar
Baxter
US Army
Daiichi Sankyo
Colorcon
Farmers Insurance

Generated: July 22, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,114,948

« Back to Dashboard

Summary for Patent: 5,114,948

Title: Stabilized pergolide compositions
Abstract:Pharmaceutical compositions containing pergolide or a salt thereof stabilized to oxidation by incorporation therewith of a stabilizing agent selected from methionine, cysteine, and cysteine hydrochloride.
Inventor(s): Conine; James W. (Indianapolis, IN), Sparks; Denis L. (Greenwood, IN), Stowers; Julian L. (Indianapolis, IN)
Assignee: Eli Lilly and Company (Indianapolis, IN)
Application Number:07/424,018
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Use;

No matches for this query

International Patent Family for Patent: 5,114,948

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia627941► Subscribe
Australia6485390► Subscribe
New Zealand235710► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Johnson and Johnson
Farmers Insurance
McKinsey
Accenture
Cantor Fitzgerald
Harvard Business School
QuintilesIMS
Novartis
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot